SS
Sumedha Sanjeev Nadkar
About Sumedha Sanjeev Nadkar
Data last updated:
Sumedha Sanjeev Nadkar was a Director at Monolom India Pharma Private Limited (2017) and Whole-Time Director at Perrigo Laboratories India Private Limited (from 2015). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Monolom India Pharma Private Limited U24303PN2017FTC188118 | Director | 27 Oct 2017 | 2017 | ₹18.17 Cr (FY 2025) | Active |
 Perrigo Laboratories India Private Limited U24230MH2005PTC240217 | Whole-Time Director | 30 Sep 2015 | 2005 | ₹33.99 Cr (FY 2022) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumedha Sanjeev Nadkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumedha Sanjeev Nadkar
Sumedha Sanjeev Nadkar was first appointed on 30 Sep 2015 as Whole-Time Director at Perrigo Laboratories India Private Limited. The most recent appointment on record is 27 Oct 2017 at Monolom India Pharma Private Limited.
Sumedha Sanjeev Nadkar held 2 earlier board appointments: Monolom India Pharma Private Limited (Director, 27 Oct 2017 to 20 Nov 2017); Perrigo Laboratories India Private Limited (Whole-Time Director, from 30 Sep 2015).